YearStart,YearEnd,LocationAbbr,LocationDesc,DataSource,Question,Age,Sex,Race_Ethnicity,Risk_Factor_Repsonse,Data_Value_Unit,Data_Value,Low_Confidence_Limit,High_Confidence_Limit,Sample_Size
2022,2022,HI,Hawaii,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,12.45,12.31,12.59,27300
2022,2022,ME,Maine,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.15,2.92,5.7,40
2022,2022,MD,Maryland,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.25,5.41,11.94,20
2022,2022,MA,Massachusetts,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.06,6.84,7.28,3750
2022,2022,OR,Oregon,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.39,7.67,9.15,470
2022,2022,DC,District Of Columbia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.82,5.78,10.3,50
2022,2022,IN,Indiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.85,6.29,7.44,520
2022,2022,KS,Kansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,9.8,8.49,11.24,180
2022,2022,MA,Massachusetts,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.4,5.85,11.59,30
2022,2022,MI,Michigan,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.67,10.62,10.72,146300
2022,2022,MN,Minnesota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.82,7.05,8.64,350
2022,2022,WY,Wyoming,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.8,5.98,7.68,240
2022,2022,KS,Kansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.2,11.11,11.3,47490
2022,2022,MT,Montana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,10.39,10.26,10.53,19850
2022,2022,WY,Wyoming,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.82,11.6,12.03,10180
2022,2022,AK,Alaska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,4.58,3.89,5.36,150
2022,2022,CO,Colorado,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.3,6.12,6.48,4370
2022,2022,DC,District Of Columbia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,6.28,6.08,6.48,3750
2022,2022,HI,Hawaii,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,10.98,10.61,11.37,2850
2022,2022,MD,Maryland,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.49,3.41,3.58,6630
2022,2022,VI,U.S. Virgin Islands,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.49,3.16,3.85,400
2022,2022,OH,Ohio,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.54,7.16,7.93,1370
2022,2022,VA,Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.8,5.43,10.78,30
2022,2022,PR,Puerto Rico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.07,8,8.14,42530
2022,2022,PR,Puerto Rico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,8.07,8,8.14,42300
2022,2022,AZ,Arizona,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.8,9.74,9.85,106700
2022,2022,IN,Indiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.8,9.74,9.85,94960
2022,2022,MA,Massachusetts,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.5,8.21,8.8,2970
2022,2022,MN,Minnesota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.03,9.96,10.1,79000
2022,2022,NE,Nebraska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,10.87,9.05,12.91,110
2022,2022,NC,North Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.5,5.23,5.77,1570
2022,2022,OK,Oklahoma,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.77,9.69,9.85,53940
2022,2022,TN,Tennessee,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.85,8.79,8.9,91100
2022,2022,VT,Vermont,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.63,8.47,8.8,9840
2022,2022,VI,U.S. Virgin Islands,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,2.62,1.89,3.54,40
2022,2022,CA,California,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.3,8.23,8.37,55200
2022,2022,FL,Florida,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,12.49,12.45,12.53,346100
2022,2022,IL,Illinois,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.11,4.91,9.89,30
2022,2022,PA,Pennsylvania,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,10.85,10.23,11.49,1040
2022,2022,TX,Texas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.5,8.47,8.53,282400
2022,2022,US,National,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.79,10.78,10.8,3924000
2022,2022,MS,Mississippi,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,5.85,4.96,6.83,150
2022,2022,MT,Montana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.44,6.61,10.57,70
2022,2022,NV,Nevada,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.06,8.96,9.16,27520
2022,2022,NJ,New Jersey,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,10.03,9.81,10.25,7050
2022,2022,OH,Ohio,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.26,9.22,9.3,164400
2022,2022,TX,Texas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.38,5.33,5.44,39080
2022,2022,WA,Washington,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,9.87,9.21,10.57,730
2022,2022,CA,California,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.08,5.04,5.12,54070
2022,2022,CT,Connecticut,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.88,8.37,9.41,1040
2022,2022,CT,Connecticut,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.11,6.83,7.39,2320
2022,2022,ME,Maine,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.97,9.86,10.09,25960
2022,2022,NV,Nevada,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.11,6.93,9.41,160
2022,2022,NJ,New Jersey,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.14,11.08,11.19,135600
2022,2022,AK,Alaska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.33,9.13,9.53,7460
2022,2022,DC,District Of Columbia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.52,5.24,8.01,80
2022,2022,IL,Illinois,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.79,7.56,8.01,4290
2022,2022,NJ,New Jersey,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,9.36,9.2,9.53,11170
2022,2022,OH,Ohio,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,6.65,4.43,9.53,30
2022,2022,PA,Pennsylvania,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,10.4,7.5,13.94,40
2022,2022,TX,Texas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,10.02,9.09,11.02,380
2022,2022,WV,West Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.99,3.57,4.44,320
2022,2022,WI,Wisconsin,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,4.14,3.84,4.46,680
2022,2022,VI,U.S. Virgin Islands,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,7.19,6.21,8.26,180
2022,2022,CO,Colorado,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.31,3.06,3.57,650
2022,2022,CT,Connecticut,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.97,4.75,5.21,1730
2022,2022,KY,Kentucky,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,5.63,4.89,6.44,200
2022,2022,ME,Maine,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,11.98,10.06,14.12,120
2022,2022,MN,Minnesota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.73,9.67,9.8,81230
2022,2022,OK,Oklahoma,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.33,10.24,10.42,48510
2022,2022,TN,Tennessee,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,10.85,8.16,14.05,50
2022,2022,WV,West Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.27,9.17,9.37,28440
2022,2022,WY,Wyoming,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.51,11.31,11.72,10550
2022,2022,NY,New York,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.65,7.55,7.74,22660
2022,2022,OR,Oregon,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.24,9.17,9.31,64130
2022,2022,OR,Oregon,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.32,2.91,3.76,240
2022,2022,RI,Rhode Island,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,,,,
2022,2022,WI,Wisconsin,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,5.19,4.73,5.68,440
2022,2022,US,National,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.53,6.5,6.55,284700
2022,2022,ID,Idaho,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.43,5.97,6.91,680
2022,2022,KY,Kentucky,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.89,2.72,3.07,1050
2022,2022,NH,New Hampshire,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,,,,
2022,2022,NM,New Mexico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.02,5.22,6.91,190
2022,2022,VI,U.S. Virgin Islands,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,,,,
2022,2022,AK,Alaska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.59,4.66,6.64,120
2022,2022,LA,Louisiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,9.8,7.06,13.15,40
2022,2022,ME,Maine,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.02,9.9,10.14,25570
2022,2022,MN,Minnesota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,6.24,5.47,7.08,220
2022,2022,NV,Nevada,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,4.42,4.24,4.61,2100
2022,2022,VT,Vermont,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,,,,
2022,2022,FL,Florida,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.47,8.27,8.69,5810
2022,2022,MA,Massachusetts,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.52,10.46,10.59,88920
2022,2022,OK,Oklahoma,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.08,6.19,8.05,210
2022,2022,DC,District Of Columbia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.49,3.3,3.69,1240
2022,2022,KS,Kansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.82,11.72,11.92,45430
2022,2022,MI,Michigan,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.62,7.27,7.99,1620
2022,2022,MS,Mississippi,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.01,10.9,11.12,33600
2022,2022,AK,Alaska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,5.7,4.59,6.99,90
2022,2022,AR,Arkansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.83,7.32,10.52,110
2022,2022,CA,California,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,7.92,7.9,7.95,390600
2022,2022,IN,Indiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,4.96,4.65,5.28,930
2022,2022,KY,Kentucky,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.16,4.51,5.87,220
2022,2022,MA,Massachusetts,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,9.37,8.78,9.98,870
2022,2022,NV,Nevada,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,5.48,4.99,6,440
2022,2022,NH,New Hampshire,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.06,5.13,7.1,140
2022,2022,ND,North Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,13.44,13.23,13.64,14440
2022,2022,OH,Ohio,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.14,7.55,8.76,660
2022,2022,UT,Utah,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,5.96,4.79,7.31,90
2022,2022,WA,Washington,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.42,9.36,9.47,102200
2022,2022,WY,Wyoming,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.55,1.9,6,10
2022,2022,IA,Iowa,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.83,6.99,8.73,290
2022,2022,KS,Kansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.6,3.33,3.9,600
2022,2022,MN,Minnesota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,4.99,4.63,5.37,690
2022,2022,NE,Nebraska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.77,11.65,11.9,30320
2022,2022,NH,New Hampshire,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.33,9.21,9.45,20940
2022,2022,SC,South Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.23,5.79,6.68,720
2022,2022,VT,Vermont,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,4.87,3.43,6.68,40
2022,2022,AL,Alabama,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.04,9.97,10.12,59330
2022,2022,GA,Georgia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,7.99,7.95,8.04,106600
2022,2022,IL,Illinois,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.05,2.97,3.13,5690
2022,2022,MD,Maryland,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,9.33,9.03,9.64,3310
2022,2022,MN,Minnesota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.86,2.61,3.13,470
2022,2022,ND,North Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,13.63,13.43,13.84,14120
2022,2022,RI,Rhode Island,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.52,7.03,8.04,800
2022,2022,FL,Florida,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,10.21,9.86,10.56,2900
2022,2022,HI,Hawaii,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,12.75,12.55,12.95,13920
2022,2022,ID,Idaho,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.67,6.65,8.79,190
2022,2022,OK,Oklahoma,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,10.37,10.03,10.71,3170
2022,2022,TN,Tennessee,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.76,9.7,9.82,86970
2022,2022,VA,Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.57,6.29,6.86,1920
2022,2022,MO,Missouri,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.75,7.18,8.34,640
2022,2022,NY,New York,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,5.32,5.24,5.4,16030
2022,2022,NY,New York,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,11.49,11.16,11.84,3940
2022,2022,OK,Oklahoma,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.02,4.66,5.4,690
2022,2022,PR,Puerto Rico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,,,,
2022,2022,CO,Colorado,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.76,10.68,10.84,68010
2022,2022,CT,Connecticut,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.35,11.26,11.43,59200
2022,2022,IL,Illinois,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.92,10.87,10.97,144700
2022,2022,IN,Indiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.4,10.33,10.46,91380
2022,2022,IA,Iowa,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,12.69,12.6,12.78,63910
2022,2022,NH,New Hampshire,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.63,7.03,10.46,90
2022,2022,NC,North Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.11,3.04,3.18,8490
2022,2022,RI,Rhode Island,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,11.44,9.89,13.14,180
2022,2022,DE,Delaware,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.75,6.96,8.61,320
2022,2022,FL,Florida,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,8.85,8.78,8.93,50580
2022,2022,GA,Georgia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,5.93,3.98,8.46,30
2022,2022,IL,Illinois,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.15,7.71,8.61,1170
2022,2022,ME,Maine,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.83,6.29,11.97,40
2022,2022,NJ,New Jersey,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,5.77,3.65,8.61,20
2022,2022,NC,North Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.88,8.84,8.93,140000
2022,2022,TN,Tennessee,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.97,7.08,8.93,270
2022,2022,AR,Arkansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.22,5.41,7.12,200
2022,2022,KY,Kentucky,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.32,8.26,8.39,55290
2022,2022,MT,Montana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.13,2.22,6.95,10
2022,2022,NM,New Mexico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.64,6.48,6.79,6510
2022,2022,RI,Rhode Island,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,6.06,5.39,6.79,280
2022,2022,FL,Florida,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.12,11.09,11.15,421300
2022,2022,KY,Kentucky,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,9.15,5.09,14.88,10
2022,2022,NE,Nebraska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.42,7.28,9.68,180
2022,2022,SD,South Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.52,11.36,11.69,15940
2022,2022,VA,Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.08,11.02,11.15,98280
2022,2022,AZ,Arizona,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.53,5.41,5.66,7370
2022,2022,CO,Colorado,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,10.04,9.97,10.11,74360
2022,2022,DE,Delaware,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,9.07,8.1,10.11,290
2022,2022,ID,Idaho,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.06,10.94,11.17,31310
2022,2022,NJ,New Jersey,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,10.97,10.46,11.5,1550
2022,2022,OK,Oklahoma,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.37,3.17,3.59,980
2022,2022,UT,Utah,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.75,11.63,11.87,35250
2022,2022,MO,Missouri,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.48,7.54,9.49,270
2022,2022,NM,New Mexico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.24,2.76,3.78,160
2022,2022,ND,North Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.18,7.01,9.49,160
2022,2022,PA,Pennsylvania,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.73,3.63,3.82,5480
2022,2022,VA,Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.63,9.58,9.69,111800
2022,2022,IA,Iowa,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,11.39,9.88,13.04,180
2022,2022,IA,Iowa,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,12.94,12.85,13.04,62730
2022,2022,OH,Ohio,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.76,5.46,6.07,1300
2022,2022,VT,Vermont,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.1,5.33,9.23,50
2022,2022,WV,West Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,,,,
2022,2022,IL,Illinois,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.58,9.53,9.62,163000
2022,2022,KY,Kentucky,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,8.68,8.61,8.75,53660
2022,2022,LA,Louisiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,8.32,7.91,8.75,1410
2022,2022,OR,Oregon,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,9.63,8.72,10.6,380
2022,2022,VA,Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.61,8.35,8.88,3710
2022,2022,WI,Wisconsin,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,5.8,5.08,6.59,220
2022,2022,PR,Puerto Rico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,,,,
2022,2022,AL,Alabama,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.56,8.49,8.62,64830
2022,2022,GA,Georgia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10,9.94,10.06,93480
2022,2022,KS,Kansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,10.69,9.2,12.32,170
2022,2022,KS,Kansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,5.72,5.11,6.38,300
2022,2022,NJ,New Jersey,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,12.26,12.19,12.32,109600
2022,2022,OR,Oregon,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.53,9.46,9.6,60590
2022,2022,WI,Wisconsin,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.43,6.6,8.32,280
2022,2022,PR,Puerto Rico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,,,,
2022,2022,AZ,Arizona,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.89,6.55,7.24,1420
2022,2022,ID,Idaho,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,6.99,5.14,9.24,50
2022,2022,LA,Louisiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.41,9.33,9.48,60190
2022,2022,LA,Louisiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.84,7.23,8.49,560
2022,2022,ME,Maine,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.99,5.68,8.49,90
2022,2022,ND,North Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.08,2.39,6.45,20
2022,2022,ND,North Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,11.84,9.18,14.95,60
2022,2022,TX,Texas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.39,10.35,10.43,222500
2022,2022,US,National,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.64,9.63,9.65,4569000
2022,2022,GA,Georgia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.68,2.63,2.74,8780
2022,2022,MS,Mississippi,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.66,5.82,7.58,210
2022,2022,MT,Montana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.07,6.04,8.23,160
2022,2022,NC,North Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,5.51,4.92,6.16,300
2022,2022,UT,Utah,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.06,5.48,6.69,370
2022,2022,VA,Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.94,8.39,9.51,920
2022,2022,WA,Washington,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.27,3.05,3.51,780
2022,2022,VI,U.S. Virgin Islands,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,9.49,5.41,15.17,20
2022,2022,FL,Florida,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.52,4.45,4.59,15630
2022,2022,NE,Nebraska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.38,2.97,3.83,240
2022,2022,AZ,Arizona,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.5,3.3,3.72,1030
2022,2022,AR,Arkansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.99,10.9,11.09,43760
2022,2022,CT,Connecticut,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,12.24,12.15,12.34,53650
2022,2022,FL,Florida,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,9.07,7.91,10.33,200
2022,2022,LA,Louisiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.59,4.48,4.69,7390
2022,2022,NV,Nevada,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.25,2.09,2.43,670
2022,2022,NH,New Hampshire,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.24,9.12,9.36,21360
2022,2022,SC,South Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.85,8.79,8.91,76590
2022,2022,SC,South Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.43,10.36,10.51,69980
2022,2022,TN,Tennessee,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,5.46,4.99,5.95,480
2022,2022,UT,Utah,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.76,6.72,8.91,180
2022,2022,VA,Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.64,3.55,3.72,6930
2022,2022,WI,Wisconsin,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.92,8.87,8.98,84470
2022,2022,WI,Wisconsin,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.32,9.26,9.38,82330
2022,2022,ME,Maine,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.03,5.73,8.52,100
2022,2022,MO,Missouri,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.3,5.86,6.77,700
2022,2022,MT,Montana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.96,7.25,10.92,90
2022,2022,NE,Nebraska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.34,11.23,11.46,31270
2022,2022,NE,Nebraska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.19,4.69,5.73,370
2022,2022,NY,New York,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,13.83,13.67,13.98,26120
2022,2022,US,National,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.38,8.24,8.52,12440
2022,2022,DE,Delaware,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,13.45,13.27,13.63,18660
2022,2022,WI,Wisconsin,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,1.68,1.54,1.83,520
2022,2022,MI,Michigan,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.44,6.16,6.74,1800
2022,2022,NH,New Hampshire,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.35,5.29,7.55,120
2022,2022,AL,Alabama,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.67,5.1,6.28,340
2022,2022,CO,Colorado,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.31,5.98,8.82,100
2022,2022,MI,Michigan,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.89,9.84,9.93,157200
2022,2022,MS,Mississippi,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.65,6.95,10.62,80
2022,2022,ND,North Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,9.49,6.77,12.84,40
2022,2022,TN,Tennessee,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.39,2.3,2.48,2740
2022,2022,WA,Washington,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.87,9.81,9.93,92550
2022,2022,DC,District Of Columbia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.02,4.26,5.86,150
2022,2022,HI,Hawaii,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,7.12,6.02,8.36,140
2022,2022,MN,Minnesota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.7,5.23,6.21,500
2022,2022,NH,New Hampshire,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.59,3.53,5.86,60
2022,2022,SC,South Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,10.1,9.06,11.2,320
2022,2022,WA,Washington,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.04,7.83,8.25,5020
2022,2022,WA,Washington,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.35,5.12,5.57,2090
2022,2022,AL,Alabama,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.49,7.34,9.75,180
2022,2022,AZ,Arizona,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.81,10.74,10.87,95020
2022,2022,DE,Delaware,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,11.27,9.57,13.16,140
2022,2022,MO,Missouri,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.98,7.33,10.87,100
2022,2022,NY,New York,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.41,6.61,8.27,290
2022,2022,OR,Oregon,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.88,6.52,7.26,1270
2022,2022,TX,Texas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.13,3.07,3.19,9850
2022,2022,NE,Nebraska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,6.25,4.66,8.18,50
2022,2022,OR,Oregon,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.2,4.91,5.49,1200
2022,2022,RI,Rhode Island,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,13.25,13.09,13.42,21280
2022,2022,SD,South Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.66,6.84,8.56,290
2022,2022,AR,Arkansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.2,4.7,5.74,370
2022,2022,CA,California,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.65,2.59,2.71,6800
2022,2022,HI,Hawaii,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,12.69,12.44,12.94,8560
2022,2022,MI,Michigan,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.11,6.29,8,260
2022,2022,MI,Michigan,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.08,3.98,4.17,6380
2022,2022,MO,Missouri,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.67,10.6,10.73,89840
2022,2022,NM,New Mexico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.09,9.96,10.22,20330
2022,2022,SD,South Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,9.87,7.65,12.48,60
2022,2022,TX,Texas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.64,7.29,8,1680
2022,2022,AL,Alabama,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3,2.91,3.09,4610
2022,2022,MD,Maryland,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.79,8.72,8.85,66840
2022,2022,MA,Massachusetts,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.99,9.93,10.05,98250
2022,2022,MO,Missouri,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.99,9.93,10.05,93690
2022,2022,MO,Missouri,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.97,2.84,3.09,2130
2022,2022,NJ,New Jersey,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,5.2,5.07,5.32,6190
2022,2022,NM,New Mexico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.75,8.65,8.85,28310
2022,2022,SD,South Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.06,1.72,5,20
2022,2022,UT,Utah,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.28,11.17,11.39,36910
2022,2022,MT,Montana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.41,7.62,9.26,380
2022,2022,PA,Pennsylvania,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.18,6.96,7.41,3580
2022,2022,WA,Washington,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,6.98,6.57,7.41,990
2022,2022,CA,California,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,6.99,6.53,7.46,820
2022,2022,CA,California,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.43,9.39,9.46,266700
2022,2022,MS,Mississippi,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,6.86,4.44,10.03,20
2022,2022,ND,North Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,7.18,5.3,9.46,50
2022,2022,SD,South Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,5.76,4.11,7.82,40
2022,2022,WY,Wyoming,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.05,4.74,10.03,30
2022,2022,PR,Puerto Rico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,8.3,7.25,9.46,210
2022,2022,CT,Connecticut,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,12.54,8.9,17.01,40
2022,2022,CT,Connecticut,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,10.43,9.5,11.42,420
2022,2022,DE,Delaware,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,,,,
2022,2022,DE,Delaware,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.9,11.75,12.06,20580
2022,2022,ID,Idaho,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.3,11.18,11.42,30130
2022,2022,IA,Iowa,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.35,5.76,6.97,410
2022,2022,KY,Kentucky,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.19,6.96,9.56,150
2022,2022,MT,Montana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.51,10.37,10.65,19140
2022,2022,NV,Nevada,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,5.25,5,5.5,1640
2022,2022,NC,North Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.22,5.88,6.57,1220
2022,2022,PA,Pennsylvania,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.37,11.33,11.42,237600
2022,2022,SC,South Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.87,6.29,12.06,40
2022,2022,TN,Tennessee,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.45,5.03,5.9,590
2022,2022,UT,Utah,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.12,5.76,6.51,970
2022,2022,AK,Alaska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.95,2.21,3.86,50
2022,2022,AR,Arkansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.79,3.62,3.97,1830
2022,2022,GA,Georgia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.71,6.45,6.98,2270
2022,2022,IN,Indiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.94,2.81,3.08,1770
2022,2022,MD,Maryland,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.84,10.76,10.93,54590
2022,2022,MS,Mississippi,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,8.77,8.69,8.86,38140
2022,2022,VT,Vermont,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,8.7,8.53,8.86,9690
2022,2022,WV,West Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.1,4.96,7.42,90
2022,2022,ID,Idaho,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,9.08,7.69,10.64,140
2022,2022,LA,Louisiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.19,11.1,11.28,50540
2022,2022,NC,North Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,10.3,10.25,10.36,127700
2022,2022,OH,Ohio,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.95,9.91,10,156500
2022,2022,OK,Oklahoma,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.04,5.46,6.65,380
2022,2022,RI,Rhode Island,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,9.09,7.93,10.36,200
2022,2022,SC,South Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.06,5.52,6.65,430
2022,2022,WY,Wyoming,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.04,5.49,11.28,30
2022,2022,AZ,Arizona,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,6.74,6.37,7.11,1200
2022,2022,MA,Massachusetts,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.23,4.03,4.43,1710
2022,2022,NV,Nevada,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,7.7,7.62,7.78,32520
2022,2022,NM,New Mexico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.33,6.89,7.78,970
2022,2022,NY,New York,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.28,11.24,11.32,303100
2022,2022,PA,Pennsylvania,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,12.15,12.1,12.2,224500
2022,2022,SD,South Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,11.32,11.16,11.48,16400
2022,2022,AK,Alaska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,11.09,10.41,11.79,890
2022,2022,AK,Alaska,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,9.74,9.51,9.97,6150
2022,2022,AZ,Arizona,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.55,7.01,8.12,670
2022,2022,AR,Arkansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,10.21,8.65,11.95,140
2022,2022,CA,California,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,6.73,6.58,6.88,7040
2022,2022,CO,Colorado,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.74,7.03,8.51,400
2022,2022,GA,Georgia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.05,4.8,5.3,1530
2022,2022,GA,Georgia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.49,6.89,8.12,540
2022,2022,KS,Kansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.72,5.34,6.11,810
2022,2022,MD,Maryland,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,6.87,6.55,7.2,1610
2022,2022,MI,Michigan,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,9.15,8.58,9.74,880
2022,2022,OH,Ohio,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.95,2.87,3.04,4530
2022,2022,SC,South Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,2.95,2.87,3.04,5110
2022,2022,SD,South Dakota,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.17,3.89,6.73,50
2022,2022,US,National,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.9,8.86,8.94,159800
2022,2022,ID,Idaho,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,9.35,7.88,10.98,130
2022,2022,NY,New York,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,12.57,12.52,12.61,234100
2022,2022,HI,Hawaii,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,17.18,11.73,23.86,30
2022,2022,MD,Maryland,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.42,7.82,9.05,670
2022,2022,CO,Colorado,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.28,5.87,6.7,830
2022,2022,NC,North Carolina,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.18,6.69,7.7,730
2022,2022,AR,Arkansas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,10.11,10.02,10.19,46410
2022,2022,HI,Hawaii,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,12.32,11.79,12.87,1800
2022,2022,IL,Illinois,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Hispanic, any race",Total,%,5.93,5.79,6.06,7150
2022,2022,WV,West Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.77,7.22,10.54,100
2022,2022,NM,New Mexico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,5.95,5.06,6.93,150
2022,2022,RI,Rhode Island,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,14.01,13.83,14.19,19810
2022,2022,US,National,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.54,3.52,3.56,152100
2022,2022,PA,Pennsylvania,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,8.73,8.43,9.03,3030
2022,2022,WV,West Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.67,6.03,9.59,70
2022,2022,WY,Wyoming,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.05,5.38,9.03,60
2022,2022,US,National,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,8.54,8.46,8.63,35640
2022,2022,VI,U.S. Virgin Islands,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,4.07,3.77,4.39,650
2022,2022,AL,Alabama,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,8.84,6.42,11.8,40
2022,2022,MS,Mississippi,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.33,3.23,3.43,4080
2022,2022,AL,Alabama,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,6.84,6.14,7.6,320
2022,2022,DE,Delaware,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.57,4.32,4.84,1170
2022,2022,IA,Iowa,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,6.35,4.15,9.22,20
2022,2022,IA,Iowa,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,4.03,3.57,4.53,270
2022,2022,LA,Louisiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,9.9,8.74,11.16,240
2022,2022,TX,Texas,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Asian,Total,%,7.6,7.45,7.76,8850
2022,2022,UT,Utah,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"Black, non-Hispanic",Total,%,3.5,2.65,4.53,60
2022,2022,VT,Vermont,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,7.24,5.29,9.63,40
2022,2022,WV,West Virginia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,All races,Total,%,9.12,9.02,9.22,29030
2022,2022,DC,District Of Columbia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,,,,
2022,2022,DC,District Of Columbia,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,"White, non-Hispanic",Total,%,11.56,11.12,12.02,2230
2022,2022,IN,Indiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,7.87,4.93,11.77,20
2022,2022,IN,Indiana,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,Other,Total,%,9.34,8.4,10.35,330
2022,2022,VT,Vermont,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,,,,
2022,2022,PR,Puerto Rico,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,,,,
2022,2022,VI,U.S. Virgin Islands,Medicare FFS MA,Annual prevalence of diagnosed age related macular degeneration,65 years and older,Both sexes,North American Native,Total,%,,,,
